Sandostatin® LAR® Delivers Powerful Efficacy and Unparalleled Evidence

Home > About Sandostatin® LAR® > Sandostatin® LAR® Core Labeling Text

Sandostatin® LAR® Core Labeling Text

The Basic Prescribing Information (BPI) is the Novartis Core Data Sheet. It displays the company’s current position on important characteristics of the product, including the Core Safety Information according to ICH E2C.

National Prescribing Information is based on the BPI. However, because regulatory requirements and medical practices vary between countries, National Prescribing Information (incl. US Package Insert or European SPCs) may differ in several respects, including but not limited to the characterization of risks and benefits.

Click here to read the Sandostatin LAR Core Labeling PDF


sandostatin.com